← Eichor
Condition: Chemotherapy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chemotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06245746Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07043894Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia
NA · 1 location(s) · Dr. Nazanin Alavi · NCT05125146Mediterranean Diet and Inequality in Early Breast Cancer
Phase 2 · 2 location(s) · Esbjerg Hospital - University Hospital of Southern Denmark · NCT07007169Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
Phase 2 · 1 location(s) · Fudan University · NCT06359275Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Affiliated Cancer Hospital & Institute of Guangzhou Medical · NCT04437329Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
Phase 1/Phase 2 · 11 location(s) · National Health Research Institutes, Taiwan · NCT05048901Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Pr
Phase 1/Phase 2 · 4 location(s) · Imunon · NCT05739981Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2
Phase 2 · 1 location(s) · Henan Cancer Hospital · NCT06176534Topotecan and Melphalan for Retinoblastoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT04799002Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an An
Phase 3 · 82 location(s) · Children's Oncology Group · NCT06647953Standardization of a Platform of Preclinical Models Derived From NSCLC Patients
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT07629375All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Nega
Phase 2 · 2 location(s) · Fudan University · NCT06636981Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
Phase 3 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05956639Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Su
NA · 7 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06351475Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
NA · 1 location(s) · Dena h. Al-Tameemi · NCT07273812PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors
Phase 1 · 1 location(s) · Shenzhen Celconta Life Science Co., Ltd. · NCT06897228A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2 · 20 location(s) · Takeda · NCT06798012Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Phase 2 · 3 location(s) · Alliance Foundation Trials, LLC. · NCT07149363Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carbo
Phase 2 · 34 location(s) · National Cancer Institute (NCI) · NCT05198830EGCG for the Prevention and Treatment of TIPN
Phase 1/Phase 2 · 1 location(s) · Han Xi Zhao · NCT06524609Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06160128Physiologic Measure of VIPN
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04786977A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperth
Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06685887HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours
Phase 1/Phase 2 · 1 location(s) · Hangzhou Hanx Biopharmaceuticals, Ltd. · NCT06708663Toripalimab With Chemotherapy for Sinus Cancer
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06940180Chemotherapy Supported by Autologous Hematopoietic Stem Cells
NA · 1 location(s) · Chongqing University Cancer Hospital · NCT05401162Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06481241Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Stud
Phase 3 · 9 location(s) · Radboud University Medical Center · NCT05333523
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.